AN2 Therapeutics Files 2025 Proxy Statement
Ticker: ANTX · Form: DEF 14A · Filed: Apr 10, 2025 · CIK: 1880438
Sentiment: neutral
Topics: proxy-statement, governance
Related Tickers: ANTX
TL;DR
AN2 Therapeutics filed its proxy statement, shareholders vote soon.
AI Summary
AN2 Therapeutics, Inc. filed its definitive proxy statement on April 10, 2025, for the fiscal year ending December 31, 2024. The filing, designated as DEF 14A, outlines the company's corporate governance and shareholder matters. The company is incorporated in Delaware and its principal executive offices are located in Menlo Park, California.
Why It Matters
This filing provides shareholders with essential information regarding upcoming votes and company leadership, enabling informed participation in corporate decision-making.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new financial or operational information that would inherently increase risk.
Key Players & Entities
- AN2 Therapeutics, Inc. (company) — Registrant
- 0000950170-25-052852 (filing_id) — Accession Number
- 20250410 (date) — Filing Date
- 1231 (date) — Fiscal Year End
- DE (state) — State of Incorporation
- Menlo Park, CA (location) — Business Address
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is filed by a company to solicit proxies from its shareholders for an upcoming shareholder meeting. It provides detailed information about the matters to be voted on, such as the election of directors, executive compensation, and other corporate proposals.
When was this DEF 14A filed by AN2 Therapeutics, Inc.?
AN2 Therapeutics, Inc. filed this DEF 14A on April 10, 2025.
What is the fiscal year end for AN2 Therapeutics, Inc. as stated in the filing?
The fiscal year end for AN2 Therapeutics, Inc. is December 31 (1231).
Where are the principal executive offices of AN2 Therapeutics, Inc. located?
The principal executive offices of AN2 Therapeutics, Inc. are located at 1800 El Camino Real, Suite D, Menlo Park, CA 94027.
What is the SIC code for AN2 Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for AN2 Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 10, 2025 regarding AN2 Therapeutics, Inc. (ANTX).